Biotechnology

Techseriesinsight > Blog > News > Biotechnology

April 3, 2025
PRNewswire
Biotechnology

UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025

UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS), generalized myasthenia gravis...

April 2, 2025
PRNewswire
Biotechnology

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD), and Leica Biosystems, a global leader in anatomic pathology...

April 1, 2025
PRNewswire
Biotechnology

Data Showcasing ALZpath’s Proprietary pTau217 Antibody at AD/PD™ 2025 Demonstrates High Rate of Reliability and Scalability for Alzheimer’s Disease Research and Diagnosis

ALZpath, Inc. (ALZpath), a leading developer of diagnostic tools and solutions for Alzheimer’s disease and related dementias, announced the inclusion of data from evaluation of blood testing platforms utilizing its...

April 1, 2025
PRNewswire
Biotechnology

Adcendo ApS Announces Changes in Board of Directors and Strengthens Executive Leadership Team

Adcendo, a biotech company pioneering the development of first- and potential best-in-class antibody-drug conjugates (ADCs) for cancers with a high unmet medical need, today announced two important Board changes...

March 27, 2025
PRNewswire
Biotechnology

Pharmaceutical Industry Veteran, Ashish Patel, PhD, Joins Nanoscope as Senior Vice President of Sales and Marketing

Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in individuals who are blind or losing vision due to various retinal degenerative diseases, today announced that Ashish Patel, PhD,...

March 26, 2025
PRNewswire
Biotechnology

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneering biotechnology company focused on developing innovative immunotherapies, today announced final data from the successful conclusion of its open-label Phase 2a...

March 25, 2025
PRNewswire
Biotechnology

AngeoPro Yeast Protein Wins 2025 World Best Ingredient Innovation Award, Pioneering a New Era of Sustainable Protein

The 2025 World Food Innovation Awards, hosted by FoodBev, took place on March 17, 2025 at the IFE International Food and Beverage Exhibition’s “Trend and Innovation Platform” in London, UK. AngeoPro Yeast...

March 25, 2025
PRNewswire
Biotechnology

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has entered into a letter of intent...

March 24, 2025
PRNewswire
Biotechnology

Tempero Bio Secures $70 Million Series B Financing to Advance TMP-301 into Phase 2 Trials for Substance Use Disorders

Tempero Bio, Inc., a clinical-stage biopharmaceutical company developing transformative treatments for substance use disorders, today announced the closing of a $70 million Series B financing. The financing was led by 8VC...

March 24, 2025
PRNewswire
Biotechnology

Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress

Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment of recurrence of Dupuytren contracture following surgical correction will...